4 Cash Heavy Small Cap Biotech Stocks Trading Near 52-Week Lows

When a company is dipping near it's 52 week low, it can mean a variety of things, one of which is that the company is poorly managed. But what if the company still has strong cash reserves? After all, having cash could fuel innovative R & D, strategic acquisitions, or long term investments, all of which could bring the stock price roaring back up. Today we focused on Biotech stocks that have taken a beating in the markets lately, but that still have cash in hand. We came up with a pretty interesting list - we hope you like it.The Current ratio is a liquidity ratio used to determine a company's financial health. The metric illustrates how easily a firm can pay back its short obligations all at once through current assets. A company that has a current ratio of one or less is generally a liquidity red flag.
... Read the rest at SeekingAlpha.com